CN106728167A - 一种烧烫伤外用杀菌止痒药膏 - Google Patents
一种烧烫伤外用杀菌止痒药膏 Download PDFInfo
- Publication number
- CN106728167A CN106728167A CN201611241565.4A CN201611241565A CN106728167A CN 106728167 A CN106728167 A CN 106728167A CN 201611241565 A CN201611241565 A CN 201611241565A CN 106728167 A CN106728167 A CN 106728167A
- Authority
- CN
- China
- Prior art keywords
- parts
- itch
- burn
- ointment
- sterilizing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000003251 Pruritus Diseases 0.000 title claims abstract description 45
- 239000002674 ointment Substances 0.000 title claims abstract description 42
- 206010053615 Thermal burn Diseases 0.000 title claims abstract description 36
- 230000001954 sterilising effect Effects 0.000 title claims abstract description 36
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 25
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229940116229 borneol Drugs 0.000 claims abstract description 25
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 25
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 25
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 18
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 14
- 241001645380 Bassia scoparia Species 0.000 claims abstract description 14
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 claims abstract description 14
- 229940046978 chlorpheniramine maleate Drugs 0.000 claims abstract description 14
- 240000000774 Cunila origanoides Species 0.000 claims abstract description 13
- 235000018274 Cunila origanoides Nutrition 0.000 claims abstract description 13
- 235000014866 Dictamnus albus Nutrition 0.000 claims abstract description 13
- 229940099259 vaseline Drugs 0.000 claims abstract description 13
- 229930003270 Vitamin B Natural products 0.000 claims abstract description 11
- 235000019156 vitamin B Nutrition 0.000 claims abstract description 11
- 239000011720 vitamin B Substances 0.000 claims abstract description 11
- 230000007803 itching Effects 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 6
- 208000002352 blister Diseases 0.000 claims abstract description 5
- 239000003814 drug Substances 0.000 claims description 26
- 239000000843 powder Substances 0.000 claims description 20
- 241000245665 Taraxacum Species 0.000 claims description 14
- 239000006071 cream Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 238000001816 cooling Methods 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 7
- 239000002390 adhesive tape Substances 0.000 claims description 6
- 239000004744 fabric Substances 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 5
- 238000002844 melting Methods 0.000 claims description 5
- 230000008018 melting Effects 0.000 claims description 5
- 231100000614 poison Toxicity 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 5
- 235000021419 vinegar Nutrition 0.000 claims description 5
- 239000000052 vinegar Substances 0.000 claims description 5
- 239000003440 toxic substance Substances 0.000 claims description 4
- 241000722953 Akebia Species 0.000 claims description 3
- 241000050051 Chelone glabra Species 0.000 claims description 3
- 241001646826 Isodon rubescens Species 0.000 claims description 3
- 241000218378 Magnolia Species 0.000 claims description 3
- 241000219099 Parthenocissus quinquefolia Species 0.000 claims description 3
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 claims description 3
- 240000004980 Rheum officinale Species 0.000 claims description 3
- 235000008081 Rheum officinale Nutrition 0.000 claims description 3
- 244000143590 Salvia chinensis Species 0.000 claims description 3
- 235000007154 Salvia chinensis Nutrition 0.000 claims description 3
- 230000035876 healing Effects 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 238000001784 detoxification Methods 0.000 claims 1
- ZOOODBUHSVUZEM-UHFFFAOYSA-N ethoxymethanedithioic acid Chemical compound CCOC(S)=S ZOOODBUHSVUZEM-UHFFFAOYSA-N 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 239000012991 xanthate Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 230000015572 biosynthetic process Effects 0.000 abstract description 5
- 230000006870 function Effects 0.000 abstract description 4
- 230000001613 neoplastic effect Effects 0.000 abstract description 4
- 240000001949 Taraxacum officinale Species 0.000 abstract description 2
- 230000000857 drug effect Effects 0.000 abstract description 2
- 230000005923 long-lasting effect Effects 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 230000008470 skin growth Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 24
- 208000027418 Wounds and injury Diseases 0.000 description 11
- 201000004624 Dermatitis Diseases 0.000 description 6
- 208000010668 atopic eczema Diseases 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000001139 anti-pruritic effect Effects 0.000 description 4
- 239000003908 antipruritic agent Substances 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000007705 chemical test Methods 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 230000036559 skin health Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 240000005717 Dioscorea alata Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010039792 Seborrhoea Diseases 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 208000008742 seborrheic dermatitis Diseases 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 241000228405 Blastomyces dermatitidis Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000034657 Convalescence Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 201000007336 Cryptococcosis Diseases 0.000 description 1
- 241000221204 Cryptococcus neoformans Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 208000013935 Electric injury Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 241000168036 Populus alba Species 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000035752 proliferative phase Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/04—Tars; Bitumens; Mineral oils; Ammonium bituminosulfonate
- A61K35/06—Mineral oils, e.g. paraffinic oils or aromatic oils based on aromatic hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Insects & Arthropods (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Animal Husbandry (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种烧烫伤外用杀菌止痒药膏,属于中医药领域。该药膏包括以下原料组成:制霉素片、维生素B片、维生素C片、冰片、苦参、地肤子、水牛角、蒲公英、白鲜皮、扑尔敏片、冰片和凡士林。本发明的药膏具有杀菌止痒、清热除湿、祛风解毒功效,对烧烫伤发痒期患者施用五秒钟即见效,使烧烫伤后皮肤生长过程中不被抓伤;同时,结合清热除湿药膏使用效果更佳,内用本发明的杀菌止痒药膏,外用清热除湿药膏,形成的双层包扎方式能够保持更持久的药效,防止杀菌止痒药膏变干变硬及粘结到新生皮肤上,拆除纱布换药时病人无疼痛感;还对各种发痒皮肤病机化脓性疱疹具有良好疗效。
Description
技术领域
本发明属于中医药领域,具体是一种烧烫伤外用杀菌止痒药膏。
背景技术
目前社会中发生的烧烫伤、化学药品灼伤以及电击伤等意外伤害疾病呈上升趋势。由于烧伤程度不同,临床表现各异,诊断标准根据皮肤烧伤的深浅分为Ⅰ度、浅Ⅱ度、深Ⅱ度和Ⅲ度。
西医烧伤外科治疗主要以外因的干扰、抗生素抗感染和手术的方式为主要特点,但用药缺乏针对性、仅重视全身用药,忽视了局部病灶的处理、患者耐受性差,心理压力大。中医自古就有“疡疮之症,最宜外治”的说法,随着近年来中医药外治烧伤的理论水平不断提高,临床经验不断丰富,越来越显示出其独特的优势,中医药治疗烧伤对烧伤创面的要求只需一般消毒即可,而且应用中药后,烧伤创面干燥结痂,大大减轻了病人换药的痛苦,具有使用方便,疗效高,见效快等特点,有西药无法比拟的效果。
利用中药膏外敷治疗烧烫伤7到10天左右,创面逐渐愈合进入恢复期,在此阶段多种因素均可能会引发新生肌肤及周围出现发痒症状,如当天气突变时,由于冷热温差和干湿的变化,引发皮肤发热出汗会感到奇痒,再如长时间贴药,由于处在增生期的皮肤组织对周围环境的物理化学因素相当敏感,引起创面周围发痒。患者常常发痒难忍到非抓破表皮见血才罢休的程度。虽然随着时间的推移,烧烫伤创面逐渐痊愈,刺痒的感觉也会随之相应地减轻和消失,但这个过程中患者身心皆受煎熬,鉴于此,本发明提供了一种快速杀菌止痒的外用型药膏。
发明内容
本发明的目的是提供一种用于烧烫伤治疗的快速杀菌止痒外用药膏。
为了达到上述目的,本发明采用以下技术方案。
一种烧烫伤外用杀菌止痒药膏,包括以下重量份的原料组成:制霉素片10-30份、维生素B片10-30份、维生素C片10-30份、冰片10-30份、苦参10-30份、地肤子10-30份、水牛角10-30份、蒲公英10-30份、白鲜皮10-30份、扑尔敏片10-30份、冰片10-30份、凡士林1000份。
作为优选,所述的烧烫伤外用杀菌止痒药膏,包括以下重量份的原料组成:制霉素片20份、维生素B片20份、维生素C片20份、冰片20份、苦参20份、地肤子20份、水牛角20份、蒲公英20份、白鲜皮20份、扑尔敏片20份、冰片20份、凡士林1000份。
上述各原料药的药理作用如下:
制霉素片:具广谱抗真菌作用,对念珠菌属的抗菌活性高,对新型隐球菌、曲菌、毛霉菌、小孢子菌、荚膜组织浆胞菌、皮炎芽生菌及皮肤癣菌有抑制作用;维生素B片:与护肤密切相关的B族维生素包括B1、B2、B3、B5、B6和H,维生素B1又称硫胺素,可抑制胆碱酯酶活性,减轻皮肤炎症反应,有防治脂溢性皮炎、湿疹、增进皮肤健康之功效,维生素B2又称核黄素,参与细胞的氧化还原反应,血红蛋白的合成及糖、蛋白质、脂肪的代谢,能帮助皮肤抵抗日光的损害,促进细胞再生,维生素B3又称为烟酸,可以抑制皮肤黑色素的形成,防止皮肤粗糙,有利于受伤害的细胞或皮肤复原,对维持正常组织,尤其是皮肤、消化道、神经系统的完整性具有重要作用,维生素B6与皮肤健康有密切关系,是很多酶和辅助酶分子结构的一部分,促进氨基酸的代谢以保持皮肤健康,可降低毛细血管壁通透性及透明质酸酶活性,降低变态反应、炎症反应,促进上皮细胞生长,可用于防治皮肤粗糙、粉刺、日光晒伤、止痒和阳光晒黑,也可用于防治脂溢性皮肤炎症、一般性痤疮、干性脂溢性皮炎湿疹和落屑性皮肤变化,维生素H又称生物素,能促进皮肤新陈代谢,改善皮肤粗糙,防止毛发脱落、脂溢性皮炎、多晶型的粉刺;维生素C片:参与机体内抗体及胶原形成,组织修补,苯丙氨酸、酪氨酸、叶酸的代谢,铁、碳水化合物的利用,脂肪、蛋白质的合成,以及维持免疫功能,羟化5-羟色胺,保持血管的完整,并促进非血红素铁的吸收;扑尔敏片:可用于治疗皮肤瘙痒症,能对抗过敏反应所致的毛细血管扩张,降低毛细血管的通透性,缓解支气管平滑肌收缩所致的喘息,能增强镇痛药作用;冰片:味辛、苦,微寒,归心、肝、肺经,清香宣散,具有清热散毒、消肿散火的功效;苦参:味苦,性寒,归心、肝、胃、大肠、膀胱经,有清热燥湿、杀虫利尿功效,用于阴肿阴痒、湿疹、湿疮、皮肤瘙痒;地肤子:味辛、苦,性寒,归肾、膀胱经,有清热利湿、祛风止痒功效,用于风疹、湿疹、皮肤瘙痒;水牛角:味苦,性寒,归心、肝经,有清热凉血、解毒定惊功效;蒲公英:味苦、甘,性寒,归肝、胃经,有清热凉血、解毒利尿、消肿散结功效;白鲜皮:味苦,性寒,归脾、胃、膀胱经,有清热燥湿、祛风解毒功效;主治湿热疮毒、湿疹、风疹、疥癣疮癞、风湿热痹,凡士林:保持皮肤组织湿润,减少空气接触和细菌感染,使创面保持自身修复能力较高的状态,不易留疤。
以上诸药中西合用,共奏杀菌止痒、清热燥湿、消肿散结、祛风解毒功效,能减轻烧烫伤发痒患者皮肤炎症反应,促进新生皮肤新陈代谢,增强其免疫能力。
本发明还提供了所述烧烫伤外用杀菌止痒药膏的制备方法,包括以下步骤:
⑴将制霉素片、维生素B片、维生素C片、扑尔敏片混合研磨,得到粉末A;
⑵将苦参、地肤子、水牛角、蒲公英、白鲜皮分别粉碎,过200-300目筛,混合得粉末B;
⑶将凡士林用80-90℃水浴,熔融后加入食醋,搅拌均匀,再加入步骤⑵粉末B,充分搅拌,降温至50-60℃,依次加入粉末A、冰片,继续充分搅拌,冷却装瓶密封即可。
本发明还提供该烧烫伤外用杀菌止痒药膏的使用方法,具体是将该烧烫伤外用杀菌止痒药膏敷于纱布内层,贴于伤面周围或烫伤愈合皮肤上,再将清热解毒膏抹于纱布外层,再包扎一层纱布,然后胶带固定,一日换一次药。所述清热解毒膏是按重量份计的大黄10-30份、白蔹10-30份、赤芍10-30份、蒲公英10-30份、黄药子10-30份、冬凌草10-30份、白鲜皮10-30份、石见穿10-30份、预知子10-30份、厚朴10-30份、生黄芩10-30份、甘草10-30份、冰片10-30份和蜂蜜1000份制成的药膏。
本发明还提供该烧烫伤外用杀菌止痒药膏在制备治疗各种发痒皮肤病的药物中的应用。
本发明还提供该烧烫伤外用杀菌止痒药膏在制备治疗化脓性疱疹的药物中的应用。
本发明的有益技术效果:本发明的药膏具有杀菌止痒、清热除湿、祛风解毒功效,对烧烫伤发痒期患者施用五秒钟即见效,使烧烫伤后皮肤生长过程中不被抓伤;同时,结合清热除湿药膏使用效果更佳,内用本发明的杀菌止痒药膏,外用清热除湿药膏,形成的双层包扎方式能够保持更持久的药效,防止杀菌止痒药膏变干变硬及粘结到新生皮肤上,拆除纱布换药时病人无疼痛感;还对各种发痒皮肤病机化脓性疱疹具有良好疗效。
具体实施方式
下面结合实施例进一步对本发明的技术方案作详细的阐述,但不都成对本发明的范围性限制。
实施例1
一种烧烫伤外用杀菌止痒药膏,包括以下重量份的原料组成:制霉素片10份、维生素B片10份、维生素C片10份、冰片10份、苦参10份、地肤子10份、水牛角10份、蒲公英10份、白鲜皮10份、扑尔敏片10份、冰片10份、凡士林1000份。
本发明还提供了所述烧烫伤外用杀菌止痒药膏的制备方法,包括以下步骤:
⑴将制霉素片、维生素B片、维生素C片、扑尔敏片混合研磨,得到粉末A;
⑵将苦参、地肤子、水牛角、蒲公英、白鲜皮分别粉碎,过200目筛,混合得粉末B;
⑶将凡士林用80℃水浴,熔融后加入食醋,搅拌均匀,再加入步骤⑵粉末B,充分搅拌,降温至50℃,依次加入粉末A、冰片,继续充分搅拌,冷却装瓶密封即可。
实施例2
一种烧烫伤外用杀菌止痒药膏,包括以下重量份的原料组成:制霉素片20份、维生素B片20份、维生素C片20份、冰片20份、苦参20份、地肤子20份、水牛角20份、蒲公英20份、白鲜皮20份、扑尔敏片20份、冰片20份、凡士林1000份。
本发明还提供了所述烧烫伤外用杀菌止痒药膏的制备方法,包括以下步骤:
⑴将制霉素片、维生素B片、维生素C片、扑尔敏片混合研磨,得到粉末A;
⑵将苦参、地肤子、水牛角、蒲公英、白鲜皮分别粉碎,过300目筛,混合得粉末B;
⑶将凡士林用90℃水浴,熔融后加入食醋,搅拌均匀,再加入步骤⑵粉末B,充分搅拌,降温至60℃,依次加入粉末A、冰片,继续充分搅拌,冷却装瓶密封即可。
实施例3
一种烧烫伤外用杀菌止痒药膏,包括以下重量份的原料组成:制霉素片30份、维生素B片30份、维生素C片30份、冰片30份、苦参30份、地肤子30份、水牛角30份、蒲公英30份、白鲜皮30份、扑尔敏片30份、冰片30份、凡士林1000份。
本发明还提供了所述烧烫伤外用杀菌止痒药膏的制备方法,包括以下步骤:
⑴将制霉素片、维生素B片、维生素C片、扑尔敏片混合研磨,得到粉末A;
⑵将苦参、地肤子、水牛角、蒲公英、白鲜皮分别粉碎,过250目筛,混合得粉末B;
⑶将凡士林用85℃水浴,熔融后加入食醋,搅拌均匀,再加入步骤⑵粉末B,充分搅拌,降温至55℃,依次加入粉末A、冰片,继续充分搅拌,冷却装瓶密封即可。
临床资料
⑴本发明人经多年临床验证,对烧烫伤二期发痒患者进行临床观察治疗。
⑵治疗方法
将实施例2制备的药膏敷于纱布内层,贴于伤面周围或烫伤愈合皮肤上,再将清热解毒膏抹于纱布外层,再包扎一层纱布,然后胶带固定,一日换一次药。所用清热解毒膏是按重量份计的大黄10-30份、白蔹10-30份、赤芍10-30份、蒲公英10-30份、黄药子10-30份、冬凌草10-30份、白鲜皮10-30份、石见穿10-30份、预知子10-30份、厚朴10-30份、生黄芩10-30份、甘草10-30份、冰片10-30份和蜂蜜1000份制成的药膏。
⑶注意事项
发痒湿热重者忌食生冷水果之物,伤口未愈者,创面周围抹药,治疗期间不可将伤口暴露,避免再次感染。
⑷疗效判定标准
治愈:发痒症状全部消失;主要理化检测指标均为正常
有效:发痒症状基本消除或减弱;主要理化检测指标有所改善
无效:主要理化检测指标与治疗前无变化。
⑸临床结果
临床治愈100%,有效率为100%,无任何不良反应。
⑹典型病例:
吕xx,女,9个月,泾川罗汉洞人,2016年6月6日火炉烫伤右脸,在市级医院住了18天未痊愈,于6月24日来我站治疗,经过祛腐生肌阶段开始长新的皮肤和肌肉组织,30号因感冒引起肺炎面部出现化脓性疱疹,使用本发明的杀菌止痒膏敷于纱布内层,贴于烫伤新生皮肤上,再将清热解毒膏抹于纱布外层,再包扎一层纱布,然后胶带固定,一日换一次药,两次后皮肤组织恢复正常。
吕xx,女,6岁,静宁县高界乡人,2016年11月10日被酒精烧伤,祛腐生肌后出现了皮肤红疹,用本发明的杀菌止痒膏敷于纱布内层,贴于烫伤新生皮肤上,再将清热解毒膏抹于纱布外层,再包扎一层纱布,然后胶带固定,一日换一次药,两次就痊愈,共治疗13天,花费人民币2000多元。
杨xx,男,彭阳县白杨镇人,19个月,胸部烫伤5天候来我站治疗,发现伤面周围有大片发痒的红疹,我们采用伤口用祛腐生肌膏,本发明的杀菌止痒膏敷于纱布内层,贴于周围发红发痒的部位上,再将清热解毒膏抹于纱布外层,再包扎一层纱布,然后胶带固定,一日换一次药,第二天伤口周围红疹明显好转,小孩皮肤也就不发痒了,第三次换药周围皮肤全好了,只给伤口贴药。
Claims (7)
1.一种烧烫伤外用杀菌止痒药膏,其特征在于,包括以下重量份的原料组成:制霉素片10-30份、维生素B片10-30份、维生素C片10-30份、冰片10-30份、苦参10-30份、地肤子10-30份、水牛角10-30份、蒲公英10-30份、白鲜皮10-30份、扑尔敏片10-30份、冰片10-30份、凡士林1000份。
2.根据权利要求1所述烧烫伤外用杀菌止痒药膏,其特征在于,包括以下重量份的原料组成:制霉素片20份、维生素B片20份、维生素C片20份、冰片20份、苦参20份、地肤子20份、水牛角20份、蒲公英20份、白鲜皮20份、扑尔敏片20份、冰片20份、凡士林1000份。
3.一种如权利要求1所述烧烫伤外用杀菌止痒药膏的制备方法,其特征在于,包括以下步骤:
⑴将制霉素片、维生素B片、维生素C片、扑尔敏片混合研磨,得到粉末A;
⑵将苦参、地肤子、水牛角、蒲公英、白鲜皮分别粉碎,过200-300目筛,混合得粉末B;
⑶将凡士林用80-90℃水浴,熔融后加入食醋,搅拌均匀,再加入步骤⑵粉末B,充分搅拌,降温至50-60℃,依次加入粉末A、冰片,继续充分搅拌,冷却装瓶密封即可。
4.一种如权利要求1所述烧烫伤外用杀菌止痒药膏的使用方法,其特征在于:具体是将所述烧烫伤外用杀菌止痒药膏敷于纱布内层,贴于伤面周围或烫伤愈合皮肤上,再将清热解毒膏抹于纱布外层,再包扎一层纱布,然后胶带固定,一日换一次药。
5.根据权利要求4所述所述烧烫伤外用杀菌止痒药膏的使用方法,其特征在于:所述清热解毒膏是按重量份计的大黄10-30份、白蔹10-30份、赤芍10-30份、蒲公英10-30份、黄药子10-30份、冬凌草10-30份、白鲜皮10-30份、石见穿10-30份、预知子10-30份、厚朴10-30份、生黄芩10-30份、甘草10-30份、冰片10-30份和蜂蜜1000份制成的药膏。
6.一种如权利要求1所述烧烫伤外用杀菌止痒药膏在制备治疗各种发痒皮肤病的药物中的应用。
7.一种如权利要求1所述烧烫伤外用杀菌止痒药膏在制备治疗化脓性疱疹的药物中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611241565.4A CN106728167B (zh) | 2016-12-29 | 2016-12-29 | 一种烧烫伤外用杀菌止痒药膏 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611241565.4A CN106728167B (zh) | 2016-12-29 | 2016-12-29 | 一种烧烫伤外用杀菌止痒药膏 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106728167A true CN106728167A (zh) | 2017-05-31 |
CN106728167B CN106728167B (zh) | 2020-07-14 |
Family
ID=58923608
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611241565.4A Expired - Fee Related CN106728167B (zh) | 2016-12-29 | 2016-12-29 | 一种烧烫伤外用杀菌止痒药膏 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106728167B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113509491A (zh) * | 2021-05-06 | 2021-10-19 | 邓军吉 | 一种用于烫伤烧伤的组合物及其制备方法与用途 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101371846A (zh) * | 2008-08-26 | 2009-02-25 | 王文丰 | 一种治疗烧伤的药水及其制备方法 |
-
2016
- 2016-12-29 CN CN201611241565.4A patent/CN106728167B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101371846A (zh) * | 2008-08-26 | 2009-02-25 | 王文丰 | 一种治疗烧伤的药水及其制备方法 |
Non-Patent Citations (3)
Title |
---|
南征等: "《任继学用药心得十讲》", 31 January 2014, 中国医药科技出版社 * |
夏照帆: "《烧伤外科学高级教程》", 31 March 2014, 人民军医出版社 * |
石净等: "皮肤科新药——止痒消炎水的研究", 《福建中医药》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113509491A (zh) * | 2021-05-06 | 2021-10-19 | 邓军吉 | 一种用于烫伤烧伤的组合物及其制备方法与用途 |
Also Published As
Publication number | Publication date |
---|---|
CN106728167B (zh) | 2020-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105030621A (zh) | 一种保湿祛痘爽肤水及其制备方法 | |
CN107308097A (zh) | 一种化妆组成物 | |
CN102178877B (zh) | 一种治疗阴囊湿疹的外用制剂及其制备方法 | |
CN102114217A (zh) | 一种治疗头癣的中药熏洗剂 | |
CN104224994B (zh) | 一种祛风除湿的中药组合物及其制备方法 | |
CN106138733A (zh) | 一种治疗皮肤病的中药膏制剂及其制备方法 | |
CN104474391A (zh) | 一种治疗皮肤瘙痒的药物 | |
CN104825941B (zh) | 一种治疗脚气的中草药组合物及其制备方法 | |
CN101164600A (zh) | 一种治疗痤疮、青春痘的药物 | |
CN105902660A (zh) | 一种治疗褥疮、糖尿病足和湿疹的药物组合物 | |
CN106728167A (zh) | 一种烧烫伤外用杀菌止痒药膏 | |
CN105381335B (zh) | 一种治疗湿疹的药物 | |
CN105031254B (zh) | 一种治疗皮炎的膏剂及其制备方法 | |
CN107648444A (zh) | 一种用于外阴脂溢性皮炎的缓释性透皮给药贴 | |
CN107095961A (zh) | 一种用于治疗青春期痤疮的中药冲剂及制备方法 | |
CN100355437C (zh) | 一种治疗烧烫伤的药物及其制备方法 | |
CN103272017B (zh) | 一种治疗烧伤烫伤的药物 | |
CN104173543B (zh) | 一种治疗失禁性皮炎的中药组合物 | |
CN108159276A (zh) | 一种熏蒸液及其制备方法和使用方法 | |
CN107019788A (zh) | 一种治疗脚气的中药组合物及其制备方法 | |
CN106668295A (zh) | 一种治疗牛皮癣的外用药物及其制备方法 | |
CN105456708A (zh) | 一种用于治疗口唇炎的药物及其制备方法 | |
CN103933428A (zh) | 一种治疗手脚癣的中药组合物 | |
CN104069056A (zh) | 舒尔肤止痒水 | |
CN104173545B (zh) | 脂溢性皮炎外用搓涂酒剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20200714 Termination date: 20201229 |
|
CF01 | Termination of patent right due to non-payment of annual fee |